TY - JOUR
T1 - Alignment of magnetic sensing and clinical magnetomyography
AU - Arekhloo, Negin Ghahremani
AU - Parvizi, Hossein
AU - Zuo, Siming
AU - Wang, Huxi
AU - Nazarpour, Kianoush
AU - Marquetand, Justus
AU - Heidari, Hadi
N1 - Funding Information:
This work was partially supported by EPSRC projects EP/X525716/1, EP/X034690/1, and EP/R004242/2. The works of NG were supported by the University of Glasgow Scholarship.
Publisher Copyright:
Copyright © 2023 Ghahremani Arekhloo, Parvizi, Zuo, Wang, Nazarpour, Marquetand and Heidari.
PY - 2023/5/18
Y1 - 2023/5/18
N2 - Neuromuscular diseases are a prevalent cause of prolonged and severe suffering for patients, and with the global population aging, it is increasingly becoming a pressing concern. To assess muscle activity in NMDs, clinicians and researchers typically use electromyography (EMG), which can be either non-invasive using surface EMG, or invasive through needle EMG. Surface EMG signals have a low spatial resolution, and while the needle EMG provides a higher resolution, it can be painful for the patients, with an additional risk of infection. The pain associated with the needle EMG can pose a risk for certain patient groups, such as children. For example, children with spinal muscular atrophy (type of NMD) require regular monitoring of treatment efficacy through needle EMG; however, due to the pain caused by the procedure, clinicians often rely on a clinical assessment rather than needle EMG. Magnetomyography (MMG), the magnetic counterpart of the EMG, measures muscle activity non-invasively using magnetic signals. With super-resolution capabilities, MMG has the potential to improve spatial resolution and, in the meantime, address the limitations of EMG. This article discusses the challenges in developing magnetic sensors for MMG, including sensor design and technology advancements that allow for more specific recordings, targeting of individual motor units, and reduction of magnetic noise. In addition, we cover the motor unit behavior and activation pattern, an overview of magnetic sensing technologies, and evaluations of wearable, non-invasive magnetic sensors for MMG.
AB - Neuromuscular diseases are a prevalent cause of prolonged and severe suffering for patients, and with the global population aging, it is increasingly becoming a pressing concern. To assess muscle activity in NMDs, clinicians and researchers typically use electromyography (EMG), which can be either non-invasive using surface EMG, or invasive through needle EMG. Surface EMG signals have a low spatial resolution, and while the needle EMG provides a higher resolution, it can be painful for the patients, with an additional risk of infection. The pain associated with the needle EMG can pose a risk for certain patient groups, such as children. For example, children with spinal muscular atrophy (type of NMD) require regular monitoring of treatment efficacy through needle EMG; however, due to the pain caused by the procedure, clinicians often rely on a clinical assessment rather than needle EMG. Magnetomyography (MMG), the magnetic counterpart of the EMG, measures muscle activity non-invasively using magnetic signals. With super-resolution capabilities, MMG has the potential to improve spatial resolution and, in the meantime, address the limitations of EMG. This article discusses the challenges in developing magnetic sensors for MMG, including sensor design and technology advancements that allow for more specific recordings, targeting of individual motor units, and reduction of magnetic noise. In addition, we cover the motor unit behavior and activation pattern, an overview of magnetic sensing technologies, and evaluations of wearable, non-invasive magnetic sensors for MMG.
KW - electromyography
KW - magnetomyography
KW - motor unit decomposition
KW - optically pumped magnetometer
KW - tunnel magnetoresistance
KW - spintronic sensors
KW - superconducting quantum interference devices
KW - wearable sensors
U2 - 10.3389/fnins.2023.1154572
DO - 10.3389/fnins.2023.1154572
M3 - Review article
SN - 1662-453X
VL - 17
SP - 1
EP - 17
JO - Frontiers in Neuroscience
JF - Frontiers in Neuroscience
ER -